David Gueyrard
2Patents
1h-index
14Co-inventors
34Inventor score
Filing activity: Aug 27, 2009 → May 10, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895744B2 | Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl | Human Necessities | 25 | Active |
| US9428500B2 | Alpha-carbolines for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.